Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

School of Pharmacy : Amal Haitham


 Last updated December 2021 - School of Pharmacy

List of Publications

(1) Mencer S, Kartawy M, Lendenfeld F, Soluh H, Tripathi MK, Khaliulin I, et al. Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway. Transl Psychiatry 2021;11(1).

(2) Hamoudi W, von Lendenfeld F, Kartawy M, Mencer S, Suloh H, Khaliulin I, et al. Regional Differences in S-Nitrosylation in the Cortex, Striatum, and Hippocampus of Juvenile Male Mice. J Mol Neurosci 2021;71(11):2383-2392.

(3) Kartawy M, Khaliulin I, Amal H. Systems biology reveals s-nitrosylation-dependent regulation of mitochondrial functions in mice with shank3 mutation associated with autism spectrum disorder. Brain Sci 2021;11(6).

(4) Khaliulin I, Ascione R, Maslov LN, Amal H, Suleiman MS. Preconditioning or postconditioning with 8-br-camp-am protects the heart against regional ischemia and reperfusion: A role for mitochondrial permeability transition. Cells 2021;10(5).

(5) Kartawy M, Khaliulin I, Amal H. Systems biology reveals reprogramming of the S-nitroso-proteome in the cortical and striatal regions of mice during aging process. Sci Rep 2020;10(1).

(6) Amal H, Barak B, Bhat V, Gong G, Joughin BA, Wang X, et al. Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Mol Psychiatry 2020;25(8):1835-1848.

(7) Tripathi MK, Kartawy M, Amal H. The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biol 2020;34.

(8) Amal H, Gong G, Yang H, Joughin BA, Wang X, Knutson CG, et al. Low doses of arsenic in a mouse model of human exposure and in neuronal culture lead to s-nitrosylation of synaptic proteins and apoptosis via nitric oxide. Int J Mol Sci 2020;21(11).

(9) Khaliulin I, Kartawy M, Amal H. Sex differences in biological processes and nitrergic signaling in mouse brain. Biomedicines 2020;8(5).

(10) Amal H, Gong G, Gjoneska E, Lewis SM, Wishnok JS, Tsai L-, et al. S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy. Transl Psychiatry 2019;9(1).

(11) Broza YY, Khatib S, Gharra A, Krilaviciute A, Amal H, Polaka I, et al. Screening for gastric cancer using exhaled breath samples. Br J Surg 2019;106(9):1122-1125.

(12) Krilaviciute A, Leja M, Kopp-Schneider A, Barash O, Khatib S, Amal H, et al. Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals. J Breath Res 2019;13(2).

(13) Amal H, Haick H. Point of care breath analysis systems. Advanced Nanomaterials for Inexpensive Gas Microsensors: Synthesis, Integration and Applications; 2019. p. 315-334.

(14) Nakhleh MK, Amal H, Jeries R, Broza YY, Aboud M, Gharra A, et al. Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules. ACS Nano 2017;11(1):112-125.

(15) Leja M, Amal H, Lasina I, Skapars R, Sivins A, Ancans G, et al. Analysis of the effects of microbiome-related confounding factors on the reproducibility of the volatolomic test. J Breath Res 2016;10(3).

(16) Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut 2016;65(3):400-407.

(17) Amal H, Leja M, Funka K, Lasina I, Skapars R, Sivins A, et al. Breath testing as potential colorectal cancer screening tool. Int J Cancer 2016;138(1):229-236.

(18) Amal H, Shi D-, Ionescu R, Zhang W, Hua Q-, Pan Y-, et al. Assessment of ovarian cancer conditions from exhaled breath. Int J Cancer 2015;136(6):E614-E622.

(19) Amal H, Shi D-, Ionescu R, Zhang W, Hua Q-, Pan YY, et al. Assessment of ovarian cancer conditions from exhaled breath. Obstet Gynecol Surv 2015;70(2):89-91.

(20) Nakhleh MK, Amal H, Awad H, Gharra A, Abu-Saleh N, Jeries R, et al. Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples. Nanomed Nanotechnol Biol Med 2014;10(8):1767-1776.

(21) Gruber M, Tisch U, Jeries R, Amal H, Hakim M, Ronen O, et al. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: A feasibility study. Br J Cancer 2014;111(4):790-798.

(22) Amal H, Leja M, Broza YY, Tisch U, Funka K, Liepniece-Karele I, et al. Geographical variation in the exhaled volatile organic compounds. J Breath Res 2013;7(4).

(23) Amal H, Ding L, Liu B-, Tisch U, Xu Z-, Shi D-, et al. The scent fingerprint of hepatocarcinoma: In-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomed 2012;7:4135-4146.

(24) Amal H, Fridman-Rozevich L, Senn R, Strelnikov A, Gafni M, Keren O, et al. Long-term consequences of a single treatment of mice with an ultra-low dose of Δ9-tetrahydrocannabinol (THC). Behav Brain Res 2010;206(2):245-253.